Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial

Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial

<i>Background and objectives</i>: Abnormal uterine bleeding is a significant clinical and gynaecological concern that necessitates its safe and effective treatment. The present study aims to compare the cost-effectiveness, safety, efficacy, and health-related quality of life of ormeloxif...

Full description

Bibliographic Details
Main Authors: Suhail Ahmad Mir, Rifat Ara, Fiza Amin, Anjum Malik, Laraibah Hamid, Tabasum Ali, Ghulam Nabi Bader, Shahid Ud Din Wani, Mansour Almuqbil, Sultan Alshehri, Abdulhakeem M. Alshehri, Faiyaz Shakeel
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Medicina
Subjects:
abnormal uterine bleeding
medroxyprogesterone acetate
ormeloxifene
selective estrogen receptor modulator
antiestrogenic
health related quality of life
Online Access:https://www.mdpi.com/1648-9144/58/11/1503

Internet

https://www.mdpi.com/1648-9144/58/11/1503

Similar Items